|L166P mutant DJ-1 promotes cell death by dissociating Bax from mitochondrial Bcl-XL.|
|Jump to Full Text|
|PMID: 22892098 Owner: NLM Status: MEDLINE|
|BACKGROUND: Mutations or deletions in DJ-1/PARK7 gene are causative for recessive forms of early onset Parkinson's disease (PD). Wild-type DJ-1 has cytoprotective roles against cell death through multiple pathways. The most commonly studied mutant DJ-1(L166P) shifts its subcellular distribution to mitochondria and renders cells more susceptible to cell death under stress stimuli. We previously reported that wild-type DJ-1 binds to Bcl-XL and stabilizes it against ultraviolet B (UVB) irradiation-induced rapid degradation. However, the mechanisms by which mitochondrial DJ-1(L166P) promotes cell death under death stimuli are largely unknown.
RESULTS: We show that DJ-1(L166P) is more prone to localize in mitochondria and it binds to Bcl-XL more strongly than wild-type DJ-1. In addition, UVB irradiation significantly promotes DJ-1(L166P) translocation to mitochondria and binding to Bcl-XL. DJ-1(L166P) but not wild-type DJ-1 dissociates Bax from Bcl-XL, thereby leading to Bax enrichment at outer mitochondrial membrane and promoting mitochondrial apoptosis pathway in response to UVB irradiation.
CONCLUSION: Our findings suggest that wild-type DJ-1 protects cells and DJ-1(L166P) impairs cells by differentially regulating mitochondrial Bax/Bcl-XL functions.
|Haigang Ren; Kai Fu; Chenchen Mu; Xuechu Zhen; Guanghui Wang|
Related Documents :
|12133548 - Renal cell carcinoma related novel gene, gylz-rcc18: cloning and functional studies.
8186888 - Polymerase chain reaction-single strand conformation polymorphism analysis of the p53 g...
3409218 - Profiles of prostaglandin biosynthesis in sixteen established cell lines derived from h...
12649338 - Galectin-1 accumulation in the ovary carcinoma peritumoral stroma is induced by ovary c...
6852148 - Use of 5-brdurd/313 nm light technique for identification of cells in initial s-phase w...
18061938 - A new biomarker for mitotic cells.
|Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2012-08-14|
|Title: Molecular neurodegeneration Volume: 7 ISSN: 1750-1326 ISO Abbreviation: Mol Neurodegener Publication Date: 2012|
|Created Date: 2012-10-24 Completed Date: 2013-06-19 Revised Date: 2013-07-12|
Medline Journal Info:
|Nlm Unique ID: 101266600 Medline TA: Mol Neurodegener Country: England|
|Languages: eng Pagination: 40 Citation Subset: IM|
|Department of Pharmacology, Laboratory of Molecular Neuropathology, Soochow University College of Pharmaceutical Sciences, Suzhou, Jiangsu 215123, People's Republic of China.|
|APA/MLA Format Download EndNote Download BibTex|
Gene Knockdown Techniques
Intracellular Signaling Peptides and Proteins / genetics*, metabolism
Mitochondria / metabolism*
Oncogene Proteins / genetics*, metabolism
bcl-2-Associated X Protein / genetics, metabolism*
bcl-X Protein / genetics, metabolism*
|0/BAX protein, human; 0/BCL2L1 protein, human; 0/Intracellular Signaling Peptides and Proteins; 0/Oncogene Proteins; 0/PARK7 protein, human; 0/bcl-2-Associated X Protein; 0/bcl-X Protein|
Journal ID (nlm-ta): Mol Neurodegener
Journal ID (iso-abbrev): Mol Neurodegener
Publisher: BioMed Central
Copyright ©2012 Ren et al.; licensee BioMed Central Ltd.
Received Day: 25 Month: 3 Year: 2012
Accepted Day: 6 Month: 8 Year: 2012
collection publication date: Year: 2012
Electronic publication date: Day: 14 Month: 8 Year: 2012
Volume: 7First Page: 40 Last Page: 40
PubMed Id: 22892098
Publisher Id: 1750-1326-7-40
|L166P mutant DJ-1 promotes cell death by dissociating Bax from mitochondrial Bcl-XL|
|Haigang Ren1||Email: firstname.lastname@example.org|
|Kai Fu1||Email: email@example.com|
|Chenchen Mu1||Email: firstname.lastname@example.org|
|Xuechu Zhen1||Email: email@example.com|
|Guanghui Wang1||Email: firstname.lastname@example.org|
1Department of Pharmacology, Laboratory of Molecular Neuropathology, Soochow University College of Pharmaceutical Sciences, Suzhou, Jiangsu, 215123, People’s Republic of China
Parkinson’s disease (PD), a common neurodegenerative movement disorder, is associated with progressive loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) . DJ-1, a product of DJ-1/PARK7 gene, was originally identified as an oncogene protein that protects cells against stress through multiple pathways including gene transcription regulation, protein stabilization, signal transduction and reactive oxygen species (ROS) elimination [2,3]. Recently, DJ-1 has attracted more attention due to its involvement in familial early onset PD as its deletion mutants or point mutations including L166P, A104T, M26I, D149A, E64D and L10P cause PD [1,4,5]. DJ-1(L166P) was the most commonly studied and traditionally considered as “loss of function by degradation” because of its instability and misfolded structure compared with wild-type DJ-1 [6-8]. In addition, DJ-1(L166P) exists as a monomer, whereas wild-type DJ-1 exists as homodimers in cells [6,9]. However, many lines of recent evidence indicated that DJ-1(L166P) renders cells more susceptible to cell death under death stimuli [10-14].
Mitochondrial dysfunction is the key and common causative factor for pathogenesis of PD [1,15-19]. In PD patients and experimental PD models, dopaminergic neurodegeneration is caused at least partly by activation of mitochondria-dependent programmed cell death 2(PCD) pathways [20,21]. For instance, positive Bax, caspase-3, caspase-9 have been observed in SNpc dopaminergic neurons in PD models [22-24]. In addition, PD-associated proteins such as PINK1, parkin and DJ-1 directly affect mitochondrial functions [25-29]. DJ-1 deficiency leads to impairments of mitochondrial connectivity, fusion rates, membrane potential (ΔΨm), respiratory capacity and ROS scavenging [25,30-33]. Interestingly, wild-type DJ-1 partially localized in mitochondria and DJ-1 mutants including L166P are more prone to mitochondrial localization [5,8,12,34,35]. Moreover, both wild-type DJ-1 and DJ-1(L166P) are enriched in the mitochondrial fraction under death stimuli [34,36]. So, it is possible that DJ-1(L166P) impairs cells or neurons by “gain of function by translocation to mitochondria”. In addition, the physiological roles of their translocation to mitochondria under oxidative stress are still unclear because wild-type DJ-1 translocation to mitochondria under oxidative stress is required for its oxidation of Cys106 , but DJ-1(L166P) can not be oxidized , suggesting that these two proteins may differentially function in mitochondria.
Recently, we reported that wild-type DJ-1 translocates to mitochondria and binds to Bcl-XL in response to UVB irradiation and inhibits Bcl-XL rapid degradation and mitochondrial apoptosis pathway induced by UVB irradiation . However, the roles of DJ-1(L166P) in mitochondria during oxidative stress are largely unknown. In this study, we further showed that DJ-1(L166P) binds more tightly to Bcl-XL than wild-type DJ-1. Under UVB irradiation, DJ-1(L166P) translocates to mitochondria to dissociate Bax from Bcl-XL by its interaction with Bcl-XL, resulting in an increased susceptibility of cells to UVB irradiation-induce cell death. Our results suggest that DJ-1 and DJ-1(L166P) differentially regulate Bcl-XL functions in control of the mitochondrial apoptotic pathway.
Considering that DJ-1 and its pathogenic mutant DJ-1(L166P) have potential functions in mitochondria, we first examined the subcellular localization of DJ-1 and DJ-1(L166P) in HEK293 cells. DJ-1-Myc was distributed diffusely in both the cytoplasm and nucleus, with a small portion co-localized with MitoTracker (green) (Figure 1A and 1B). However, DJ-1(L166P)-Myc was dominantly presented in the mitochondria with much less nuclear and cytosolic distribution (Figure 1A). Quantitative analysis showed that approximately 81.3% of cells transfected with DJ-1(L166P) displayed a mitochondrial localization, and approximately 18.7% of them displayed a cytosolic localization (Figure 1B). Consistent with the immunocytochemical results, subcellular fractionation assays also showed that both of distribution ratio and protein level of DJ-1(L166P) in the mitochondrial fraction were much higher than those of wild-type DJ-1, although the total protein level of DJ-1(L166P) was much less than that of wild-type DJ-1 (Figure 1C and 1D). The lower level of Flag-DJ-1(L166P) protein compared to Flag-DJ-1 should be caused by that L166P mutant is unstable and degraded rapidly through the ubiquitin proteasome system (UPS), when equal amounts of plasmids are used for transfection [6,7,38]. The mitochondrial localization of wild-type DJ-1 and its mutants increases under oxidative stresses such as paraquat treatment,H2O2 and UV irradiation [34,36]. Consistent with those findings, we observed that UVB irradiation increased the mitochondrial localization of both endogenous DJ-1 and Flag-DJ-1(L166P), but did not change total protein levels of them (Figure 1E and 1F). These results indicated that DJ-1(L166P) is prone to mitochondrial localization and the mitochondrial distribution of wild-type DJ-1 and DJ-1(L166P) are increased in response to UVB irradiation.
In our previous study, we showed that wild-type DJ-1 translocates to mitochondria to bind to Bcl-XL in response to UVB irradiation . Considering that DJ-1(L166P) is mainly distributed in mitochondria, and translocates more to mitochondria under oxidative stress, we wonder whether DJ-1(L166P) binds to Bcl-XL. Although the interactions of wild-type DJ-1 and DJ-1(L166P) with Bcl-XL were not significant different in GST pulldown assays in vitro (Figure 2A), more DJ-1(L166P) than wild-type DJ-1 bound to Bcl-XL in cells (Figure 2B). Neither wild-type DJ-1 nor DJ-1(L166P) bound to Bcl2 and Bax, another two typical Bcl-2 family proteins (data not shown). These data suggested that wild-type DJ-1 and DJ-1(L166P) specifically bind to Bcl-XL. The monoclonal anti-Bcl-XL antibody used in Figure 2B is suitable for immunoprecipitation assays as Flag-Bcl-XL could be immunoprecipitated by anti-Bcl-XL antibody but not by control mouse serum IgG ( Additional file 1: Figure S1). Consistent with data from immunoprecipitation analyses, immunocytochemical studies showed that DJ-1(L166P)-Myc, but not DJ-1-Myc, was well co-localized with EGFP-Bcl-XL in HEK293 cells (Figure 2C). We also examined the interactions between Bcl-XL and another pathogenic DJ-1 mutant, DJ-1(M26I). Similar to DJ-1(L166P), DJ-1(M26I) interacted with Bcl-XL and co-localized with Bcl-XL ( Additional file 1: Figure: S2). As DJ-1(L166P) increased in mitochondria under UVB irradiation (Figure 1E and 1F), we next performed immunoprecipitation assays to test if the interaction of Bcl-XL with DJ-1(L166P) is affected by UVB irradiation. Interestingly, the binding affinity of Flag-DJ-1(L166P) for EGFP-Bcl-XL significantly increased after UVB irradiation (Figure 2D). In addition, UVB irradiation led to larger punctate DJ-1(L166P)-RFP spots co-localizing with EGFP- Bcl-XL (Figure 2E). Moreover, the mitochondria exhibited more severe abnormalities in cells harboring DJ-1(L166P) under UVB irradiation (Figure 2E).
We previously found that wild-type DJ-1 mainly binds to amino acids 86–195 of Bcl-XL which contain BH1, BH2 and BH3 domains . We wonder whether DJ-1(L166P) binds to the same amino acids of Bcl-XL. Surprisingly, DJ-1(L166P) bound to the C-terminal fragment of Bcl-XL at amino acids 196–233 (Figure 3A). We further examined the regions of Bcl-XL binding to DJ-1(L166P) in H1299 cells. Similar to the results from GST pulldown assays, EGFP-Bcl-XL196-233 but not EGFP-Bcl-XL1-195 was found to interact with Flag-DJ-1(L166P) (Figure 3B). These results suggest that DJ-1(L166P) and wild-type DJ-1 bind to different domains of Bcl-XL, indicating that they may regulate Bcl-XL functions differently. Under UVB irradiation, Bcl-XL is degraded via the UPS [39,40]. In our previous study, we showed that wild-type DJ-1 stabilizes Bcl-XL by its inhibiting Bcl-XL under UVB irradiation. We therefore examined if DJ-1(L166P) also stabilize Bcl-XL. Under UVB irradiation, knockdown of DJ-1 decreased Bcl-XL protein levels and re-overexpression of Flag-DJ-1(s), a synonymous mutant that is resistant to si-DJ-1, restored Bcl-XL protein levels, however, Flag-DJ-1(L166P)(s) did not (Figure 3C and 3D). Meanwhile, the ubiquitination of Bcl-XL was inhibited by DJ-1 but not DJ-1(L166P) (Figure 3E).
Bcl-2 family proteins mediate apoptosis in a manner dependent on their homo- or hetero-dimerization . Bcl-XL interacts with Bax to block its oligomerization in the mitochondrial membrane, thereby protecting cells from Bax-induced mitochondrial membrane permeabilization [41-43]. It has been reported that the BH1-2 domains and the C-terminus of Bcl-XL are required for Bcl-XL/Bax heterodimer formation [43,44]. To investigate if DJ-1(L166P) affects the interactions between Bcl-XL and Bax or Bcl-2, we performed competitive binding assays. With less amount of His-DJ-1(L166P), more Bax bound to Bcl-XL (Figure 4A). However, the binding ability of Bcl-2 to Bcl-XL was not affected by His-DJ-1(L166P) (Figure 4B). To further identify if DJ-1(L166P) influences the interactions between Bcl-XL and Bax in mammalian cells, we transfected various amounts of Flag-DJ-1(L166P) into H1299 cells stably expressing EGFP-Bcl-XL or EGFP-Bcl-XL1-195 and performed immunoprecipitation assays. Under UVB irradiation, the amount of endogenous Bax that interacted with EGFP-Bcl-XL was decreased when more Flag-DJ-1(L166P) was inputted (Figure 4C and 4D). However, EGFP-Bcl-XL1-195, which does not interact with Bax , was unable to interact with DJ-1(L166P) (Figure 4C).
The mitochondrial localization of Bax is important for its ability to induce cell death . Because DJ-1 and DJ-1(L166P) re-distribute to mitochondria upon UVB irradiation but differentially influence Bcl-XL, we performed cytosolic and mitochondrial fractionation assays and MTT assays to examine the effects of DJ-1 and DJ-1(L166P) on mitochondrial Bax translocation and cell viability. We performed experiments in H1299 cells, a p53 null cell line to exclude the possibility that DJ-1 inhibits Bax transcription by binding to p53 [45-47]. Because endogenous DJ-1 expression is abundant , we constructed a H1299 cell line stably transfected with sh-DJ-1 to silence endogenous DJ-1 to examine the effects of exogenous wild-type DJ-1 and DJ-1(L166P).
The knockdown efficiency of sh-DJ-1 is shown in Figure 5A and 5B. In the absence of UVB irradiation, neither Flag-DJ-1(s) nor Flag-DJ-1(L166P)(s) had significant effects on the translocation of Bax from the cytosol to the mitochondria in sh-DJ-1 cells (Figure 5C and 5D). However, under UVB irradiation, less Bax was presented in the mitochondrial fraction in cells transfected with Flag-DJ-1(s), but more Bax was present in the mitochondrial fraction in cells transfected with Flag-DJ-1(L166P)(s) (Figure 5C and 5D). Overexpression of Flag-DJ-1(s) but not Flag-DJ-1(L166P)(s) significantly increased mitochondrial Bcl-XL in response to UVB irradiation (Figure 5C and 5E). In addition, in the absence of death stimulus, overexpression of Flag-DJ-1(s) or Flag-DJ-1(L166P)(s) had no significant effects on Bcl-XL levels, caspase-3 and PARP cleavage (Figure 5F) or cell viability (Figure 5G). However, with UVB irradiation, Flag-DJ-1(s) partially restored Bcl-XL levels and accordingly inhibited the cleavage of caspase-3 and PARP (Figure 5F) and increased cell viability (Figure 5G). In contrast to Flag-DJ-1(s), Flag-DJ-1(L166P)(s) greatly increased the cleavage of both caspase-3 and PARP (Figure 5F) and decreased cell viability (Figure 5G). Moreover, the effects of DJ-1 and DJ-1(L166P) on cell death under UVB irradiation were abrogated by Bcl-XL knockdown (Figure 5F and 5G). These results suggest that wild-type DJ-1 protects cells against UVB irradiation by inhibiting Bcl-XL degradation, but DJ-1(L166P) promotes cell death by dissociating Bcl-XL/Bax heterodimerization.
Many studies have shown that wild-type DJ-1 and DJ-1(L166P) are partially localized in mitochondria [5,8,12,34,35], and that their mitochondrial distribution is enhanced under death stimuli [34,36]. Several lines of evidence indicate that wild-type DJ-1 exhibits its cytoprotective roles by maintaining mitochondrial integrity, fusion rates, membrane potential, respiratory capacity and ROS elimination [25,30-33].
In our previous study, we identified that wild-type DJ-1 is a novel partner of Bcl-XL in mitochondria, to stabilize Bcl-XL. Here, we found that DJ-1(L166P) binds to Bcl-XL as well. However, DJ-1(L166P) does not stabilize Bcl-XL but dissociates Bax from Bcl-XL. The binding ability of DJ-1(L166P) to Bcl-XL is stronger than that of wild-type DJ-1 (Figure 2B). In contrast to DJ-1 that interacts with Bcl-XL dependent on its oxidation , DJ-1(L166P) interacts with Bcl-XL independent on its oxidation as DJ-1(L166P) is a loss of oxidized form . In addition, DJ-1(L166P) binds to the C-terminus of Bcl-XL (Figure 3A and 3B) which is required for Bcl-XL/Bax heterodimer formation , but wild-type DJ-1 mainly binds to middle regions (Figure 3A) containing BH1, BH2 and BH3 domains which are essential for Bcl-XL stability [49,50]. Wild-type DJ-1 and DJ-1(L166P) that bind to different domains of Bcl-XL may be due to the fact that L166P mutant interrupts the normal folding and exposes new domains or amino acid sites [38,51,52]. Taken together, our study suggests that the different roles of DJ-1 and DJ-1(L166P) in mitochondria may result from the different oxidative status of these two proteins and from their functioning differentially in mitochondria.
L166P mutant prevents normal folding of wild-type DJ-1 and itself is instable with a rapid degradation via UPS [6,7,51,52]. However, DJ-1(L166P) appears not only to be “loss of function” of wild-type DJ-1. It also forms larger complexes with other proteins but not wild-type DJ-1 . Although DJ-1(L166P) loses the ability to bind to proteins that wild-type DJ-1 does, such as Daxx , DJ-1(L166P) existing as a monomer in cells may allow it to gain an ability to bind to proteins that wild-type DJ-1 does not. For instance, DJ-1(L166P) and DJ-1(M26I) bind more TTRAP than wild-type DJ-1 does, and they block the protective activity of TTRAP, leading to cell death . Wild-type DJ-1 represses UV-induced JNK activation to protects cells, but DJ-1(L166P) significantly activates JNK pathway to promote cell death in response to UV irradiation . As much more DJ-1(L166P) is translocated to mitochondria than wild-type DJ-1 under UVB stimulation, and DJ-1(L166P), but not wild-type DJ-1, dissociates Bax from mitochondrial Bcl-XL, it is therefore possible that DJ-1(L166P) may gain functions by translocation to mitochondria to affect mitochondrial pathway. We also found that another PD-associated mutant DJ-1(M26I) mainly distributes in mitochondria and binds to Bcl-XL, similar to DJ-1(166P) (Additional file 1: Figure S2). These results suggest that the mitochondrial Bcl-XL/Bax pathway influenced by mutant DJ-1 might be a common mechanism involved in mutant DJ-1-associated PD pathogenesis.
Mitochondrial dysfunction is a key feature involved in both sporadic and genetic forms of PD [1,15-19]. Although familial PD is rare, to understand the mechanisms and functions of familial PD-associated proteins in mitochondria may shed light on the pathogenesis of PD. Our findings suggest that wild-type DJ-1 and DJ-1(L166P) differentially mediate Bcl-XL functions providing us to further understand the pathogenesis of PD.
We found that a small portion of wild-type DJ-1 and most of DJ-1(L166P) is presented in mitochondria and wild-type DJ-1 and DJ-1(L166P) increased in mitochondria in response to UVB irradiation. DJ-1(L166P) binds to mitochondrial Bcl-XL more tightly than wild-type DJ-1 and UVB irradiation further promotes their binding affinity. Unlike wild-type DJ-1, DJ-1(L166P) fails to stabilize Bcl-XL, but it dissociates Bax from Bcl-XL that leading Bax enrichment in outer mitochondrial membrane and subsequently triggers cell death in response to UV irradiation. Our findings suggest that wild-type DJ-1 protects cells and DJ-1(L166P) impairs cells by differentially regulating Bcl-XL functions. Our study provides a novel insight into the underlying mechanisms of PD pathogenesis.
Human HEK293 cells, a human kidney cell line, and H1299 cells, a human lung cancer cell line, were maintained in DMEM (Dulbecco’s modified Eagle’s medium) supplemented with 10% fetal bovine serum (Hyclone, USA). Plasmid transfections were performed using Lipofectamine2000 reagent (Invitrogen, USA).
HEK293 or H1299 cells were irradiated with UVB using a UV crosslinker. Briefly, the cultured cells covered with a thin layer of phosphate buffer solution (PBS, pH 7.4), were exposed to UVB irradiation (312 nm) with 80 mJ/cm2 with a UV crosslinker (SCIENTZ03-II, Ningbo, China). After UVB irradiation, the cells were cultured for 16 hours and subsequently subjected to additional experiments.
si-DJ-1328 was described previously . siRNA against human Bcl-XL mRNA was purchased from GenePharma (GenePharma, Shanghai, China) with the following sequences: sense: 5′-GAGAUGCAGGUAUUGGUGATT-3′, anti-sense: 5′-UCACCAAUACCUGCAUCUCTT-3′. The oligonucleotides were transfected with Oligofectamine reagent (Invitrogen, USA). Briefly, cultured cells were washed with Opti-MEM medium (Invitrogen) and then transfected with siRNA using Oligofectamine reagent in Opti-MEM medium without serum. Six hours after transfection, the culture medium was replaced with fresh complete medium. The cells were subjected to further experiments 72 hours after transfection. pGPU6/GFP/Neo-sh-DJ-1 encoding a short hairpin RNA (shRNA) against nucleotide 328 to 346 of human DJ-1 mRNA (sh-DJ-1) or a negative control short hairpin (sh-NC) was constructed by GenePharma (GenePharma, Shanghai, China). H1299 cells stably expressing sh-NC or sh-DJ-1 were obtained by selection with 200 μg/ml Geneticin (Invitrogen, USA) after transfection.
Full-length DJ-1 in p3 × Flag-myc-cmv-24, pET-15b, pDsRed-N1, pmyc-cmv-24 and pGEX-5x-1, and pET-21a-Bcl2, pET-21a-Bax, pET-21a-Bcl-XL, pEGFP-C2-Bcl-XL, p3 × Flag-myc-cmv-24-Bcl-XL, pGEX-5x-1-Bcl-XL(1–85), pGEX-5x-1-Bcl-XL(86–195) and pGEX-5x-1-Bcl-XL(196–233) were described previously . pEGFP-C2-Bcl-XL(1–195) and pEGFP-C2-Bcl-XL(196–233) were created by subcloning PCR products into pEGFP-C2 at its EcoRI/SalI sites. The PCR products were amplified with the following primers: 5′-CGGAATTCATGTCTCAGAGCAAC-3′ and 5′-GCGTCGACTCAATAGAGTTCCACAAA-3′ for 1-195aa; 5′-CGGAATTCGGGAACAATGCAGCA-3′ and 5′-GCGTCGACTCATTTCCGACTGAAG-3′ for 196-233aa. DJ-1(L166P) and DJ-1(M26I) mutants were obtained by site-directed mutagenesis using wild-type DJ-1 plasmids as template with the following primers: 5′-CCTGCAATTGTTGAAGCCCTGGAATG-3′ and 5′-CGCAAACTCGAAGCTGGTCCCAG-3′, for DJ-1(L166P); 5′-GTAGATGTCATTAGGCGA-3′ and 5′-GGTGACCTTAATCCCAGC-3′, for DJ-1(M26I); respectively. Two synonymous mutants, p3 × Flag-myc-cmv-24-DJ-1(s) and p3 × Flag-myc-cmv-24-DJ-1(L166P)(s), that are resistant to si-DJ-1328 and sh-DJ-1 were described previously .
HEK293 cells were washed with PBS and fixed with 4% paraformaldehyde. After being blocked with 4% fetal bovine serum containing 0.25% Triton X-100 in PBS, the cells incubated with rabbit anti-myc polyclonal antibodies (Santa Cruz Biotechnology, USA) followed by an incubation with rhodamine-conjugated donkey anti-rabbit IgG (Santa Cruz biotech, Inc). After staining with DAPI (4′,6-diamidino-2-phenylindole), the labeled cells were observed using an inverted fluorescent microscope (Olympus, IX71).
Equal amounts of GST or GST-fused proteins (20 μg) expressed by Escherichia coli strain JM109 were incubated with 20 μl of glutathione agarose beads (Pharmacia, USA) for 30 min at 4°C. After washing three times with ice-cold PBS, the beads were incubated with 50 μg of His-fused protein expressed by Escherichia coli strain BL21 for 2 hours at 4°C. After incubation, the beads were washed five times with ice-cold HNTG buffer (20 mM Hepes-KOH, pH 7.5, 100 mM NaCl, 0.1% Triton X-100 and 10% glycerol). Bound proteins were eluted from the beads and subjected to immunoblot analysis with specific antibodies. The input represents 10% of the protein that was incubated with GST or a GST-fused protein. The inputs of purified GST and GST fusion proteins are stained with Coomassie Brilliant Blue (CBB) or anti-GST antibody.
The cells were lysed in 1 ml cell lysis buffer (50 mM Tris–HCl pH 7.5 buffer containing 150 mM NaCl, 1% NP40 and 0.5% deoxycholate) supplemented with the protease inhibitor cocktail (Roche, USA) for 30 min at 4°C. After centrifugation at 12,000 g for 15 min at 4°C, the supernatants were incubated with appropriate antibodies coupled to protein G Sepharose (Roche, USA). The immunoprecipitants were then washed five times with cell lysis buffer. Bound proteins and cell lysates were subjected to immunoblot analysis. The input represents 10% of the supernatant used in the co-immunoprecipitation experiment.
Proteins were separated by 12% or 15% SDS-PAGE and subjected to immunoblot analysis with specific antibodies. The following primary antibodies were used: Monoclonal anti-Bcl2, anti-Bcl-XL, anti-GFP, anti-GST, anti-Tom20, anti-Ub and polyclonal anti-Myc, anti-Bax, anti-Max antibodies were purchased from Santa Cruz Biotechnology. Polyclonal anti-Bcl-XL, anti-cleaved caspase-3 and anti-PARP antibodies were from Cell Signaling. Polyclonal anti-DJ-1 antibodies were purchased from Chemicon. Monoclonal anti-Flag-HRP and anti-α-Tubulin antibodies were purchased from Sigma. Monoclonal anti-GAPDH antibody was from Millipore. The secondary antibodies, sheep anti-mouse IgG-HRP and anti-rabbit IgG-HRP were purchased from Amersham Pharmacia Biotech. The proteins were visualized using an ECL detection kit (Amersham Pharmacia Biotech). Immunoblot densitometric analysis of data from three independent experiments was performed using Photoshop 7.0 (Adobe, USA).
The cytosolic and mitochondrial fractions were isolated using Mitochondria Isolation Kit for Cultured Cells (Beyotime, China). The total cell lysates and isolated fractions were subjected to immunoblot analysis with specific antibodies. Tom20, α-Tubulin and Max served as the mitochondrial, cytosolic and nuclear maker, respectively.
The cell viability was measured by MTT (methylthiazoletetrazolium) assay. Briefly, the cells were washed with DMEM without phenol red (Gibco, USA) and incubated with 0.5 mg/ml MTT (Sigma) for three hours. The medium was removed and the formazan crystals were dissolved in DMSO (dimethyl sulfoxide). Cell viability was measured by spectrometry at OD570. The data were normalized to a control and the ratios are presented as means ± S.E.M from three independent experiments.
The data were analyzed by one-way analysis of variance (ANOVA) using origin 6.0 software (Originlab, USA). Values are shown as mean ± S.E.M.
ANOVA: Analysis of variance; CBB: Coomassie brilliant blue; DAPI: 4′,6-diamidino-2-phenylindole; EGFP: Enhanced green fluorescent proteins; HRP: Horseradish peroxidase; PD: Parkinson’s disease; PBS: Phosphate buffer solution; ROS: Reactive oxygen species; SNpc: Substantia nigra pars compacta; UPS: Ubiquitin proteasome system; UVB: Ultraviolet B.
The authors declare that they have no competing interests.
RHG designed and carried out all the experiments, and drafted the manuscript. FK and MCC participated in experiments and manuscript. ZXC edited the manuscript. WGH conceived and designed the study, and edited the manuscript. All authors read and approved the final manuscript.
Figure S1. Anti-Bcl-XL antibody was suitable for immunoprecipitation. The supernatants of HEK293 cells that were transiently transfected with Flag-Bcl-XL were subjected to immunoprecipitation analysis using normal mouse serum or anti-Bcl-XL antibody. Figure S2. DJ-1(M26I) also interacted and co-localized with Bcl-XL in cells. (A) HEK293 cells were co-transfected with EGFP or EGFP-Bcl-XL along with Flag-DJ-1, Flag-DJ-1(L166P) or Flag-DJ-1(M26I) as indicated, the supernatants of cell lysates were subjected to immunoprecipitation analysis using anti-GFP antibodies. (B) HEK293 cells transiently transfected with DJ-1(M26I)-Myc with EGFP-Bcl-XL were subjected to immunocytochemical staining with anti-Myc antibodies (red), Bar, 10 μm.
This work was supported in part by the National High-tech Research and Development program of China 973-projects (2011CB504102), the National Natural Sciences Foundation of China (No. 30970921 and 31100768) and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions.
|Moore DJ,West AB,Dawson VL,Dawson TM,Molecular pathophysiology of Parkinson’s diseaseAnnu Rev NeurosciYear: 200528578710.1146/annurev.neuro.28.061604.13571816022590|
|Nagakubo D,Taira T,Kitaura H,Ikeda M,Tamai K,Iguchi-Ariga SM,Ariga H,DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with rasBiochem Biophys Res CommunYear: 199723150951310.1006/bbrc.1997.61329070310|
|da Costa CA,DJ-1: a newcomer in Parkinson’s disease pathologyCurr Mol MedYear: 2007765065710.2174/15665240778256442618045143|
|Guo JF,Xiao B,Liao B,Zhang XW,Nie LL,Zhang YH,Shen L,Jiang H,Xia K,Pan Q,et al. Mutation analysis of Parkin, PINK1, DJ-1 and ATP13A2 genes in Chinese patients with autosomal recessive early-onset ParkinsonismMov DisordYear: 2008232074207910.1002/mds.2215618785233|
|Bonifati V,Rizzu P,van Baren MJ,Schaap O,Breedveld GJ,Krieger E,Dekker MC,Squitieri F,Ibanez P,Joosse M,et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonismScienceYear: 200329925625910.1126/science.107720912446870|
|Moore DJ,Zhang L,Dawson TM,Dawson VL,A missense mutation (L166P) in DJ-1, linked to familial Parkinson’s disease, confers reduced protein stability and impairs homo-oligomerizationJ NeurochemYear: 2003871558156710.1111/j.1471-4159.2003.02265.x14713311|
|Miller DW,Ahmad R,Hague S,Baptista MJ,Canet-Aviles R,McLendon C,Carter DM,Zhu PP,Stadler J,Chandran J,et al. L166P mutant DJ-1, causative for recessive Parkinson’s disease, is degraded through the ubiquitin-proteasome systemJ Biol ChemYear: 2003278365883659510.1074/jbc.M30427220012851414|
|Macedo MG,Anar B,Bronner IF,Cannella M,Squitieri F,Bonifati V,Hoogeveen A,Heutink P,Rizzu P,The DJ-1L166P mutant protein associated with early onset Parkinson’s disease is unstable and forms higher-order protein complexesHum Mol GenetYear: 2003122807281610.1093/hmg/ddg30412952867|
|Junn E,Jang WH,Zhao X,Jeong BS,Mouradian MM,Mitochondrial localization of DJ-1 leads to enhanced neuroprotectionJ Neurosci ResYear: 20098712312910.1002/jnr.2183118711745|
|Zucchelli S,Vilotti S,Calligaris R,Lavina ZS,Biagioli M,Foti R,De Maso L,Pinto M,Gorza M,Speretta E,et al. Aggresome-forming TTRAP mediates pro-apoptotic properties of Parkinson’s disease-associated DJ-1 missense mutationsCell Death DifferYear: 20091642843810.1038/cdd.2008.16919023331|
|Mo JS,Kim MY,Ann EJ,Hong JA,Park HS,DJ-1 modulates UV-induced oxidative stress signaling through the suppression of MEKK1 and cell deathCell Death DifferYear: 2008151030104110.1038/cdd.2008.2618309325|
|Shinbo Y,Niki T,Taira T,Ooe H,Takahashi-Niki K,Maita C,Seino C,Iguchi-Ariga SM,Ariga H,Proper SUMO-1 conjugation is essential to DJ-1 to exert its full activitiesCell Death DifferYear: 2006139610810.1038/sj.cdd.440170415976810|
|Taira T,Saito Y,Niki T,Iguchi-Ariga SM,Takahashi K,Ariga H,DJ-1 has a role in antioxidative stress to prevent cell deathEMBO RepYear: 2004521321810.1038/sj.embor.740007414749723|
|Deeg S,Gralle M,Sroka K,Bahr M,Wouters FS,Kermer P,BAG1 restores formation of functional DJ-1 L166P dimers and DJ-1 chaperone activityJ Cell BiolYear: 201018850551310.1083/jcb.20090410320156966|
|Winklhofer KF,Haass C,Mitochondrial dysfunction in Parkinson’s diseaseBiochim Biophys ActaYear: 20101802294410.1016/j.bbadis.2009.08.01319733240|
|Bueler H,Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson’s diseaseExp NeurolYear: 200921823524610.1016/j.expneurol.2009.03.00619303005|
|Martin I,Dawson VL,Dawson TM,Recent advances in the genetics of Parkinson’s diseaseAnnu Rev Genomics Hum GenetYear: 20111230132510.1146/annurev-genom-082410-10144021639795|
|de Moura MB,dos Santos LS,Van Houten B,Mitochondrial dysfunction in neurodegenerative diseases and cancerEnviron Mol MutagenYear: 20105139140520544881|
|Henchcliffe C,Beal MF,Mitochondrial biology and oxidative stress in Parkinson disease pathogenesisNat Clin Pract NeurolYear: 2008460060918978800|
|Perier C,Bove J,Vila M,Mitochondria and programmed cell death in Parkinson’s disease: apoptosis and beyondAntioxid Redox SignalYear: 20121688389510.1089/ars.2011.407421619488|
|Vila M,Przedborski S,Targeting programmed cell death in neurodegenerative diseasesNat Rev NeurosciYear: 2003436537510.1038/nrn110012728264|
|Viswanath V,Wu Y,Boonplueang R,Chen S,Stevenson FF,Yantiri F,Yang L,Beal MF,Andersen JK,Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson’s diseaseJ NeurosciYear: 2001219519952811739563|
|Tatton NA,Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson’s diseaseExp NeurolYear: 2000166294310.1006/exnr.2000.748911031081|
|Hartmann A,Michel PP,Troadec JD,Mouatt-Prigent A,Faucheux BA,Ruberg M,Agid Y,Hirsch EC,Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson’s disease?J NeurochemYear: 2001761785179310.1046/j.1471-4159.2001.00160.x11259496|
|Thomas KJ,McCoy MK,Blackinton J,Beilina A,van der Brug M,Sandebring A,Miller D,Maric D,Cedazo-Minguez A,Cookson MR,DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagyHum Mol GenetYear: 201120405010.1093/hmg/ddq43020940149|
|McCoy MK,Cookson MR,DJ-1 regulation of mitochondrial function and autophagy through oxidative stressAutophagyYear: 2011753153210.4161/auto.7.5.1468421317550|
|Kamp F,Exner N,Lutz AK,Wender N,Hegermann J,Brunner B,Nuscher B,Bartels T,Giese A,Beyer K,et al. Inhibition of mitochondrial fusion by alpha-synuclein is rescued by PINK1, Parkin and DJ-1EMBO JYear: 2010293571358910.1038/emboj.2010.22320842103|
|Cookson MR,DJ-1, PINK1, and their effects on mitochondrial pathwaysMov DisordYear: 201025Suppl 1S44S4820187230|
|Van Laar VS,Berman SB,Mitochondrial dynamics in Parkinson’s diseaseExp NeurolYear: 200921824725610.1016/j.expneurol.2009.03.01919332061|
|Irrcher I,Aleyasin H,Seifert EL,Hewitt SJ,Chhabra S,Phillips M,Lutz AK,Rousseaux MW,Bevilacqua L,Jahani-Asl A,et al. Loss of the Parkinson’s disease-linked gene DJ-1 perturbs mitochondrial dynamicsHum Mol GenetYear: 2010193734374610.1093/hmg/ddq28820639397|
|Hao LY,Giasson BI,Bonini NM,DJ-1 is critical for mitochondrial function and rescues PINK1 loss of functionProc Natl Acad Sci U S AYear: 20101079747975210.1073/pnas.091117510720457924|
|Blackinton J,Lakshminarasimhan M,Thomas KJ,Ahmad R,Greggio E,Raza AS,Cookson MR,Wilson MA,Formation of a stabilized cysteine sulfinic acid is critical for the mitochondrial function of the parkinsonism protein DJ-1J Biol ChemYear: 20092846476648519124468|
|Ved R,Saha S,Westlund B,Perier C,Burnam L,Sluder A,Hoener M,Rodrigues CM,Alfonso A,Steer C,et al. Similar patterns of mitochondrial vulnerability and rescue induced by genetic modification of alpha-synuclein, parkin, and DJ-1 in Caenorhabditis elegansJ Biol ChemYear: 2005280426554266810.1074/jbc.M50591020016239214|
|Canet-Aviles RM,Wilson MA,Miller DW,Ahmad R,McLendon C,Bandyopadhyay S,Baptista MJ,Ringe D,Petsko GA,Cookson MR,The Parkinson’s disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localizationProc Natl Acad Sci U S AYear: 20041019103910810.1073/pnas.040295910115181200|
|Zhang L,Shimoji M,Thomas B,Moore DJ,Yu SW,Marupudi NI,Torp R,Torgner IA,Ottersen OP,Dawson TM,Dawson VL,Mitochondrial localization of the Parkinson’s disease related protein DJ-1: implications for pathogenesisHum Mol GenetYear: 2005142063207310.1093/hmg/ddi21115944198|
|Blackinton J,Ahmad R,Miller DW,van der Brug MP,Canet-Aviles RM,Hague SM,Kaleem M,Cookson MR,Effects of DJ-1 mutations and polymorphisms on protein stability and subcellular localizationBrain Res Mol Brain ResYear: 2005134768315790532|
|Ren H,Fu K,Wang D,Mu C,Wang G,Oxidized DJ-1 Interacts with the Mitochondrial Protein BCL-XLJ Biol ChemYear: 2011286353083531710.1074/jbc.M110.20713421852238|
|Olzmann JA,Brown K,Wilkinson KD,Rees HD,Huai Q,Ke H,Levey AI,Li L,Chin LS,Familial Parkinson’s disease-associated L166P mutation disrupts DJ-1 protein folding and functionJ Biol ChemYear: 20042798506851514665635|
|Zhang H,Rosdahl I,Bcl-xL and bcl-2 proteins in melanoma progression and UVB-induced apoptosisInt J OncolYear: 20062866166616465371|
|Park K,Lee JH,Bcl-XL protein is markedly decreased in UVB-irradiated basal cell carcinoma cell lines through proteasome-mediated degradationOncol RepYear: 20092168969219212627|
|Youle RJ,Strasser A,The BCL-2 protein family: opposing activities that mediate cell deathNat Rev Mol Cell BiolYear: 20089475910.1038/nrm230818097445|
|Yang E,Zha J,Jockel J,Boise LH,Thompson CB,Korsmeyer SJ,Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell deathCellYear: 19958028529110.1016/0092-8674(95)90411-57834748|
|Yin XM,Oltvai ZN,Korsmeyer SJ,BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with BaxNatureYear: 199436932132310.1038/369321a08183370|
|Jeong SY,Gaume B,Lee YJ,Hsu YT,Ryu SW,Yoon SH,Youle RJ,Bcl-x(L) sequesters its C-terminal membrane anchor in soluble, cytosolic homodimersEMBO JYear: 2004232146215510.1038/sj.emboj.760022515131699|
|Giaime E,Sunyach C,Druon C,Scarzello S,Robert G,Grosso S,Auberger P,Goldberg MS,Shen J,Heutink P,et al. Loss of function of DJ-1 triggered by Parkinson’s disease-associated mutation is due to proteolytic resistance to caspase-6Cell Death DifferYear: 20101715816910.1038/cdd.2009.11619680261|
|Bretaud S,Allen C,Ingham PW,Bandmann O,p53-dependent neuronal cell death in a DJ-1-deficient zebrafish model of Parkinson’s diseaseJ NeurochemYear: 20071001626163517166173|
|Fan J,Ren H,Jia N,Fei E,Zhou T,Jiang P,Wu M,Wang G,DJ-1 decreases Bax expression through repressing p53 transcriptional activityJ Biol ChemYear: 20082834022403018042550|
|Bandopadhyay R,Kingsbury AE,Cookson MR,Reid AR,Evans IM,Hope AD,Pittman AM,Lashley T,Canet-Aviles R,Miller DW,et al. The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson’s diseaseBrainYear: 200412742043010.1093/brain/awh05414662519|
|Feng Y,Zhang L,Hu T,Shen X,Ding J,Chen K,Jiang H,Liu D,A conserved hydrophobic core at Bcl-xL mediates its structural stability and binding affinity with BH3-domain peptide of pro-apoptotic proteinArch Biochem BiophysYear: 2009484465410.1016/j.abb.2009.01.00319161970|
|Sattler M,Liang H,Nettesheim D,Meadows RP,Harlan JE,Eberstadt M,Yoon HS,Shuker SB,Chang BS,Minn AJ,et al. Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosisScienceYear: 199727598398610.1126/science.275.5302.9839020082|
|Wilson MA,Collins JL,Hod Y,Ringe D,Petsko GA,The 1.1-A resolution crystal structure of DJ-1, the protein mutated in autosomal recessive early onset Parkinson’s diseaseProc Natl Acad Sci U S AYear: 20031009256926110.1073/pnas.113328810012855764|
|Tao X,Tong L,Crystal structure of human DJ-1, a protein associated with early onset Parkinson’s diseaseJ Biol ChemYear: 2003278313723137910.1074/jbc.M30422120012761214|
|Junn E,Taniguchi H,Jeong BS,Zhao X,Ichijo H,Mouradian MM,Interaction of DJ-1 with Daxx inhibits apoptosis signal-regulating kinase 1 activity and cell deathProc Natl Acad Sci U S AYear: 20051029691969610.1073/pnas.040963510215983381|
|Ren H,Fu K,Mu C,Li B,Wang D,Wang G,DJ-1, a cancer and Parkinson’s disease associated protein, regulates autophagy through JNK pathway in cancer cellsCancer LettYear: 201029710110810.1016/j.canlet.2010.05.00120510502|
Keywords: Parkinson’s disease, DJ-1, L166P, Mitochondria, Apoptosis, Bcl-XL, Bax, UVB.
Previous Document: Proteolytic profiling and comparative analyses of active trypsin-like serine peptidases in preimagin...
Next Document: Copper effects on key metabolic enzymes and mitochondrial membrane potential in gills of the estuari...